Revenue And Margin ExpansionA large revenue step-up in 2025 combined with high gross and operating margins indicates the business can scale while maintaining strong unit economics. Durable margins and rapid top-line growth support reinvestment for product development and distribution expansion over the next several quarters.

Materially Improved Leverage And ReturnsA very low debt-to-equity ratio and healthy ROE improve financial flexibility, lowering insolvency risk and enabling funded R&D, partnerships, or selective M&A. Strong equity growth and conservative leverage support operational resilience through industry cycles over the medium term.

Cash-supported EarningsFCF tracking reported net income so closely signals high earnings quality and cash-conversion potential. That alignment supports sustainable investment in commercialization, steady working-capital needs, and the ability to fund collaborations or licensing without immediate external financing.

Bears Say

Margin Compression Versus Prior YearsCompression from previously higher gross and net margins suggests rising input costs, pricing pressure, or less favorable product mix as the company scales. Persisting margin erosion could weaken free cash generation and limit room for sustained R&D or distributor incentives over coming quarters.

Operating Cash Flow Decline And FCF VolatilityDespite profitable income, declining operating cash flow and falling FCF indicate variability in cash conversion. This volatility constrains the company's ability to consistently self-fund growth initiatives and raises funding risk if margins or revenue momentum soften over a multi-quarter horizon.

Recentness Of Financial RecoveryHistorical negative equity and former high leverage mean current strength is relatively recent, so sustainability is unproven. If growth slows or cash volatility persists, the company may face financing or governance pressures that expose residual balance-sheet fragility.

153A FAQ

What was Caulis, Inc.’s price range in the past 12 months?

Caulis, Inc. lowest stock price was ¥688.00 and its highest was ¥2888.00 in the past 12 months.

What is Caulis, Inc.’s market cap?

Caulis, Inc.’s market cap is ¥7.13B.

When is Caulis, Inc.’s upcoming earnings report date?

Caulis, Inc.’s upcoming earnings report date is May 14, 2026 which is in 83 days.

How were Caulis, Inc.’s earnings last quarter?

Caulis, Inc. released its earnings results on Feb 13, 2026. The company reported ¥8.88 earnings per share for the quarter, beating the consensus estimate of N/A by ¥8.88.

Is Caulis, Inc. overvalued?

According to Wall Street analysts Caulis, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Caulis, Inc. pay dividends?

Caulis, Inc. pays a Notavailable dividend of ¥4.8 which represents an annual dividend yield of N/A. See more information on Caulis, Inc. dividends here

What is Caulis, Inc.’s EPS estimate?

Caulis, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Caulis, Inc. have?

Caulis, Inc. has 6,528,000 shares outstanding.

What happened to Caulis, Inc.’s price movement after its last earnings report?

Caulis, Inc. reported an EPS of ¥8.88 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.985%.

Which hedge fund is a major shareholder of Caulis, Inc.?

Currently, no hedge funds are holding shares in JP:153A

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Caulis, Inc.

Caulis, Inc. (153A) is a biotechnology company specializing in the development of innovative agricultural solutions and biopesticides aimed at enhancing crop productivity and sustainability. The company focuses on harnessing natural plant-based compounds and advanced biotechnological methods to create products that protect crops from pests and diseases while minimizing environmental impact. Caulis, Inc. operates primarily within the agricultural sector, catering to farmers and agricultural businesses seeking eco-friendly alternatives to traditional chemical pesticides.